7NR9
Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E+ |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2016-06-01 |
Detector | DECTRIS EIGER R 1M |
Wavelength(s) | 1.54178 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 48.786, 71.096, 60.566 |
Unit cell angles | 90.00, 108.71, 90.00 |
Refinement procedure
Resolution | 46.210 - 1.906 |
R-factor | 0.2483 |
Rwork | 0.245 |
R-free | 0.30810 |
Structure solution method | FOURIER SYNTHESIS |
RMSD bond length | 0.013 |
RMSD bond angle | 1.100 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | BUSTER |
Refinement software | BUSTER (2.11.7 (19-MAR-2020)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.210 | 1.920 |
High resolution limit [Å] | 1.906 | 1.906 |
Rmeas | 0.173 | 2.507 |
Number of reflections | 30520 | 588 |
<I/σ(I)> | 3.6 | 0.4 |
Completeness [%] | 99.4 | 98.4 |
Redundancy | 3.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 291 | 0.25M (NH4)2SO4 33% MPEG 2000 .02M Mercaptoethanol .1M pH=7.2 HEPES/NaOH |